The British-Swedish drugmaker has joined with a huge Asian company to produce a Covid-19 vaccine in China, where shady reputations are common in the pharmaceutical industry.
Tag: AstraZeneca PLC
Johnson Basks in a Rare Burst of Good U.K. News
The current lockdown is ending and a successful British vaccine could vanquish the virus by spring. But will that be enough to rebuild his sagging political fortunes?
AstraZeneca and Oxford Say Vaccine Is Up to 90 Percent Effective
In an early analysis, the drug maker zeroed in on a promising dosing plan for its vaccine.
How the Out-of-Control Pandemic Is Speeding the Testing of Vaccines
The surge in coronavirus cases worldwide is helping researchers measure more quickly how well their vaccines protect against Covid-19.
The Race for a Super-Antibody Against the Coronavirus
A network of scientists is chasing the pandemic’s holy grail: an antibody that protects against not just the virus, but also related pathogens that may threaten humans.
How to Ship a Vaccine at –80°C, and Other Obstacles in the Covid Fight
Developing an effective vaccine is the first step. Then comes the question of how to deliver hundreds of millions of doses that may need to be kept at arctic temperatures.
Safety Review Begins Into AstraZeneca’s Coronavirus Vaccine Trial
A participant in the company’s late-stage coronavirus vaccine trial reportedly developed severe neurological symptoms. Now experts must assess whether the vaccine was responsible.
AstraZeneca Pauses Vaccine Trial for Safety Review
The company halted late-stage trials of its coronavirus vaccine because of a serious suspected adverse reaction in a participant.
Coronavirus Crisis Has Made Brazil an Ideal Vaccine Laboratory
Widespread contagion, a deep bench of scientists and a robust vaccine-making infrastructure have made Brazil an important player in the quest to find a vaccine.
Oxford Covid Vaccine Among Those Developers Say Have Promising Initial Results
Early trials showed a good immune response in vaccinated subjects, but one researcher sounded a note of caution: “There is still a long way to go.”